Breaking News Instant updates and real-time market news.

CHTR

Charter

$821.02 /

+2.7 (+0.33%)

08:18
09/03/21
09/03
08:18
09/03/21
08:18

Charter downgraded to Hold on valuation at TD Securities

TD Securities analyst Vince Valentini downgraded Charter Communications to Hold from Buy with a price target of $870, up from $840. The analyst cites valuation for the downgrade with the shares up 24% year-to-date. The stock could pullback over the next few months if interest rates rise and/or investors rotate out of growth into value and cyclical names, Valentini tells investors in a research note. The analyst also believes Charter shares are pricing in "consistent earning beats and positive estimate revisions," which could lead to some near-term profit taking.

CHTR Charter
$821.02 /

+2.7 (+0.33%)

09/03/21 TD Securities
Charter downgraded to Hold from Buy at TD Securities
08/24/21 Pivotal Research
Charter price target raised to $1,000 from $820 at Pivotal Research
08/11/21 Argus
Charter price target raised to $900 from $775 at Argus
08/02/21 JPMorgan
Charter price target raised to $855 from $750 at JPMorgan

TODAY'S FREE FLY STORIES

Upgrade
Maxeon Solar upgraded to Buy from Neutral at BofA » 06:06
12/03/21
12/03
06:06
12/03/21
06:06
MAXN

Maxeon Solar

$17.09 /

+0.145 (+0.86%)

BofA analyst Julien…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

11/16/21 Roth Capital
Roth says court restoring solar 'bifi' exemption a 'major surprise'
11/11/21 Morgan Stanley
Commerce rejection negative for First Solar, Maxeon, says Morgan Stanley
10/05/21 Raymond James
Maxeon Solar downgraded to Outperform from Strong Buy at Raymond James
08/09/21 Morgan Stanley
Maxeon Solar initiated with an Equal Weight at Morgan Stanley
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

  • 16
    Apr
MAXN Maxeon Solar
$17.09 /

+0.145 (+0.86%)

Earnings
Big Lots cuts FY21 EPS view to $5.70-$5.85 from $5.90-$6.05, consensus $5.97 » 06:06
12/03/21
12/03
06:06
12/03/21
06:06
BIG

Big Lots

$43.62 /

+0.935 (+2.19%)

The company said,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

Recommendations
Ulta Beauty price target raised to $475 from $433 at Piper Sandler » 06:05
12/03/21
12/03
06:05
12/03/21
06:05
ULTA

Ulta Beauty

$383.13 /

+12.8 (+3.46%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

10/20/21 Cowen
Ulta Beauty price target lowered to $440 from $490 at Cowen
10/20/21 BofA
Ulta Beauty price target lowered to $400 from $430 at BofA
10/20/21 William Blair
Ulta Beauty should be bought on yesterday's selloff, says William Blair
10/20/21 Baird
Ulta Beauty risk/reward attractive at current levels, says Baird
ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

ULTA Ulta Beauty
$383.13 /

+12.8 (+3.46%)

Earnings
Big Lots sees Q4 EPS $2.05-$2.20, consensus $2.39 » 06:05
12/03/21
12/03
06:05
12/03/21
06:05
BIG

Big Lots

$43.62 /

+0.935 (+2.19%)

Sees Q4 comparable sales…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

Initiation
Radius Health initiated with an Underperform at BofA » 06:04
12/03/21
12/03
06:04
12/03/21
06:04
RDUS

Radius Health

$16.05 /

+0.505 (+3.25%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

11/09/21 H.C. Wainwright
Radius Health price target lowered to $23 from $26 at H.C. Wainwright
10/21/21 H.C. Wainwright
Radius Health price target raised to $26 from $19 at H.C. Wainwright
10/20/21 Stifel
Success of Radius' elacestrant lowers risk for Arvinas' ARV-471, says Stifel
10/20/21 Stifel
Stifel ups Radius Health target to $22 following EMERALD Phase 3 trial data
RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

RDUS Radius Health
$16.05 /

+0.505 (+3.25%)

Initiation
Stoke Therapeutics initiated with a Buy at BofA » 06:04
12/03/21
12/03
06:04
12/03/21
06:04
STOK

Stoke Therapeutics

$23.83 /

+0.83 (+3.61%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

11/22/21 JPMorgan
Stoke Therapeutics upgraded to Overweight from Neutral at JPMorgan
08/17/21 Cantor Fitzgerald
Stoke Therapeutics price target lowered to $68 from $76 at Cantor Fitzgerald
06/30/21 Canaccord
Stoke Therapeutics leader in Dravet Syndrome approach, says Canaccord
05/18/21 UBS
Stoke Therapeutics initiated with a Neutral at UBS
STOK Stoke Therapeutics
$23.83 /

+0.83 (+3.61%)

Recommendations
Marvell price target raised to $100 from $70 at Piper Sandler » 06:04
12/03/21
12/03
06:04
12/03/21
06:04
MRVL

Marvell

/

+

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
/

+

MRVL Marvell
/

+

05:57 Today Cowen
Marvell upgraded to Outperform after 'watershed' quarter at Cowen
05:40 Today Cowen
Marvell upgraded to Outperform from Market Perform at Cowen
05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

MRVL Marvell
/

+

Initiation
Agios Pharmaceuticals initiated with a Buy at BofA » 06:04
12/03/21
12/03
06:04
12/03/21
06:04
AGIO

Agios Pharmaceuticals

$34.78 /

-0.23 (-0.66%)

BofA analyst Greg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

07/30/21
Fly Intel: Top five analyst downgrades
07/30/21 H.C. Wainwright
Agios Pharmaceuticals price target raised to $93 from $88 at H.C. Wainwright
07/30/21 Goldman Sachs
Agios Pharmaceuticals downgraded to Sell from Neutral at Goldman Sachs
07/01/21 Raymond James
Agios Pharmaceuticals initiated with a Market Perform at Raymond James
AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

AGIO Agios Pharmaceuticals
$34.78 /

-0.23 (-0.66%)

Earnings
Big Lots reports Q3 EPS (14c), consensus (16c) » 06:03
12/03/21
12/03
06:03
12/03/21
06:03
BIG

Big Lots

$43.62 /

+0.935 (+2.19%)

Reports Q3 revenue…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

09/21/21
Fly Intel: Top five analyst downgrades
09/21/21 Piper Sandler
Big Lots downgraded to Neutral from Overweight at Piper Sandler
09/07/21 JPMorgan
Big Lots price target lowered to $54 from $71 at JPMorgan
08/30/21 Loop Capital
Big Lots price target lowered to $50 from $60 at Loop Capital
BIG Big Lots
$43.62 /

+0.935 (+2.19%)

BIG Big Lots
$43.62 /

+0.935 (+2.19%)

Earnings
AirSculpt Technologies sees FY21 revenue $130M, consensus $129.82M » 06:03
12/03/21
12/03
06:03
12/03/21
06:03
AIRS

AirSculpt Technologies

$10.55 /

+0.33 (+3.23%)

Sees FY21 adjusted EBITDA…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIRS AirSculpt Technologies
$10.55 /

+0.33 (+3.23%)

11/23/21 SVB Leerink
SVB Leerink bullish on AirSculpt Technologies, initiates with an Outperform
11/23/21 Morgan Stanley
Morgan Stanley starts AirSculpt Technologies at Overweight, sees 25% upside
11/23/21 SVB Leerink
AirSculpt Technologies initiated with an Outperform at SVB Leerink
11/23/21 Raymond James
AirSculpt Technologies initiated with an Outperform at Raymond James
AIRS AirSculpt Technologies
$10.55 /

+0.33 (+3.23%)

  • 29
    Oct
AIRS AirSculpt Technologies
$10.55 /

+0.33 (+3.23%)

Recommendations
Ollie's Bargain Outlet price target lowered to $79 from $90 at Piper Sandler » 06:03
12/03/21
12/03
06:03
12/03/21
06:03
OLLI

Ollie's Bargain Outlet

$63.05 /

+1.9 (+3.11%)

Piper Sandler analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

05:37 Today JPMorgan
Ollie's Bargain Outlet downgraded to Underweight from Neutral at JPMorgan
09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy on pullback at Berenberg
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy from Hold at Berenberg
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

Earnings
AirSculpt Technologies reports Q3 revenue $34.7M, consensus $34.3M » 06:02
12/03/21
12/03
06:02
12/03/21
06:02
AIRS

AirSculpt Technologies

$10.55 /

+0.33 (+3.23%)

Net income was $8.1M as…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AIRS AirSculpt Technologies
$10.55 /

+0.33 (+3.23%)

11/23/21 SVB Leerink
SVB Leerink bullish on AirSculpt Technologies, initiates with an Outperform
11/23/21 Morgan Stanley
Morgan Stanley starts AirSculpt Technologies at Overweight, sees 25% upside
11/23/21 SVB Leerink
AirSculpt Technologies initiated with an Outperform at SVB Leerink
11/23/21 Raymond James
AirSculpt Technologies initiated with an Outperform at Raymond James
  • 29
    Oct
AIRS AirSculpt Technologies
$10.55 /

+0.33 (+3.23%)

Upgrade
BP upgraded to Buy on 'strong' fundamental's at Deutsche Bank » 06:01
12/03/21
12/03
06:01
12/03/21
06:01
BP

BP

$27.07 /

+1.345 (+5.23%)

Deutsche Bank analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BP BP
$27.07 /

+1.345 (+5.23%)

BP BP
$27.07 /

+1.345 (+5.23%)

05:24 Today Deutsche Bank
BP upgraded to Buy from Hold at Deutsche Bank
11/29/21 JPMorgan
BP price target raised to 570 GBp from 530 GBp at JPMorgan
11/09/21 Morgan Stanley
BP price target raised to 401 GBp from 388 GBp at Morgan Stanley
10/25/21 TD Securities
BP initiated with a Hold at TD Securities
BP BP
$27.07 /

+1.345 (+5.23%)

BP BP
$27.07 /

+1.345 (+5.23%)

BP BP
$27.07 /

+1.345 (+5.23%)

BP BP
$27.07 /

+1.345 (+5.23%)

Downgrade
National Bank of Canada downgraded to Hold from Buy at Desjardins » 05:59
12/03/21
12/03
05:59
12/03/21
05:59
NTIOF

National Bank of Canada

$75.10 /

+0.32 (+0.43%)

Desjardins analyst Doug…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
NTIOF National Bank of Canada
$75.10 /

+0.32 (+0.43%)

12/02/21 Canaccord
National Bank of Canada price target lowered to C$105 at Canaccord
12/02/21 CIBC
National Bank of Canada price target lowered to C$108 from C$112 at CIBC
12/02/21 RBC Capital
National Bank of Canada price target raised to C$111 from C$99 at RBC Capital
12/02/21 Scotiabank
National Bank of Canada price target lowered to C$112 from C$114 at Scotiabank
Upgrade
Marvell upgraded to Outperform after 'watershed' quarter at Cowen » 05:57
12/03/21
12/03
05:57
12/03/21
05:57
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Cowen analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

05:40 Today Cowen
Marvell upgraded to Outperform from Market Perform at Cowen
05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
11/30/21 BMO Capital
Marvell price target raised to $85 from $70 at BMO Capital
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Downgrade
Smith & Wesson downgraded to Market Perform on 'big miss' at Cowen » 05:55
12/03/21
12/03
05:55
12/03/21
05:55
SWBI

Smith & Wesson Brands

$22.94 /

+0.405 (+1.80%)

Cowen analyst Cai von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

05:38 Today Cowen
Smith & Wesson downgraded to Market Perform from Outperform at Cowen
09/02/21 Lake Street
Smith & Wesson undervalued after 'another strong quarter,' says Lake Street
06/21/21 Lake Street
Smith & Wesson Brands price target raised to $43 from $34 at Lake Street
03/05/21
Fly Intel: Top five analyst downgrades
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

Initiation
Peloton initiated with a Buy at Deutsche Bank » 05:52
12/03/21
12/03
05:52
12/03/21
05:52
PTON

Peloton

$44.45 /

+2.14 (+5.06%)

Deutsche Bank analyst…

Deutsche Bank analyst Chris Woronka initiated coverage of Peloton Interactive with a Buy rating and $76 price target. While there there are scenarios in which Peloton shares go lower from here, there are more scenarios that result in greater upside based on a "fundamental and unemotional analysis" of the company's earnings power in a "normalized," fully-reopened economic environment, Woronka tells investors in a research note. The analyst thinks the hybrid work model extends to fitness and that Peloton "has plenty of momentum to regain operationally." If the stock "can regain its footing for fundamental reasons, it has quite a bit of room to run," contends Woronka.

ShowHide Related Items >><<
PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

11/29/21 Stifel
Peloton price target lowered to $56 from $70 at Stifel
11/16/21 Baird
Baird adds Peloton as 'Fresh Pick,' says capital raise removes overhang
11/16/21 BMO Capital
Peloton 'backpedaling again' with $1B offering, says BMO Capital
11/11/21 RBC Capital
Affirm price target raised to $175 from $130 at RBC Capital
PTON Peloton
$44.45 /

+2.14 (+5.06%)

  • 16
    Nov
PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

PTON Peloton
$44.45 /

+2.14 (+5.06%)

Upgrade
Raymond James upgrades Fastly on selloff, uptick in traffic » 05:50
12/03/21
12/03
05:50
12/03/21
05:50
FSLY

Fastly

$36.47 /

+0.365 (+1.01%)

Raymond James analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

04:50 Today Raymond James
Fastly upgraded to Outperform from Market Perform at Raymond James
09/08/21 Evercore ISI
Evercore says Akamai, Cloudflare, Fastly may partner with Apple on new service
08/09/21 Raymond James
Fastly reinstated with a Market Perform at Raymond James
08/05/21
Fly Intel: Top five analyst downgrades
FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

FSLY Fastly
$36.47 /

+0.365 (+1.01%)

Downgrade
Novartis downgraded to Neutral on pipeline concerns at Bryan Garnier » 05:46
12/03/21
12/03
05:46
12/03/21
05:46
NVS

Novartis

$79.96 /

+0.11 (+0.14%)

Bryan Garnier analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

05:20 Today Bryan Garnier
Novartis downgraded to Neutral from Buy at Bryan Garnier
11/05/21 UBS
Novartis downgraded to Neutral on lower near-term growth at UBS
11/05/21 UBS
Novartis downgraded to Neutral from Buy at UBS
10/27/21 JPMorgan
Novartis price target lowered to CHF 80 from CHF 84 at JPMorgan
NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

NVS Novartis
$79.96 /

+0.11 (+0.14%)

Upgrade
Marvell upgraded to Outperform from Market Perform at Cowen » 05:40
12/03/21
12/03
05:40
12/03/21
05:40
MRVL

Marvell

$71.02 /

+0.18 (+0.25%)

Cowen analyst Karl…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

05:11 Today Oppenheimer
Marvell price target raised to $110 from $100 at Oppenheimer
12/01/21 Susquehanna
Marvell price target raised to $82 from $75 at Susquehanna
11/30/21 BMO Capital
Marvell price target raised to $85 from $70 at BMO Capital
11/29/21 B. Riley
Marvell price target raised to $90 from $83 at B. Riley
MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

MRVL Marvell
$71.02 /

+0.18 (+0.25%)

Downgrade
Smith & Wesson downgraded to Market Perform from Outperform at Cowen » 05:38
12/03/21
12/03
05:38
12/03/21
05:38
SWBI

Smith & Wesson Brands

$22.94 /

+0.405 (+1.80%)

Cowen analyst Cai Von…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

09/02/21 Lake Street
Smith & Wesson undervalued after 'another strong quarter,' says Lake Street
06/21/21 Lake Street
Smith & Wesson Brands price target raised to $43 from $34 at Lake Street
03/05/21
Fly Intel: Top five analyst downgrades
03/05/21 Lake Street
Smith & Wesson Brands price target raised to $34 from $28 at Lake Street
SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

SWBI Smith & Wesson Brands
$22.94 /

+0.405 (+1.80%)

Hot Stocks
BeiGene announces China NMPA approval for Sylvant » 05:37
12/03/21
12/03
05:37
12/03/21
05:37
BGNE

BeiGene

$346.46 /

-7.365 (-2.08%)

BeiGene announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

10/12/21
Fly Intel: Top five analyst initiations
10/12/21 Bernstein
BeiGene initiated with Outperform, $431 price target at Bernstein
10/12/21 Bernstein
BeiGene initiated with an Outperform at Bernstein
10/06/21 CLSA
CLSA double upgrades BeiGene to Buy on anti-BTK potential
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

Downgrade
Ollie's Bargain Outlet downgraded to Underweight from Neutral at JPMorgan » 05:37
12/03/21
12/03
05:37
12/03/21
05:37
OLLI

Ollie's Bargain Outlet

$63.05 /

+1.9 (+3.11%)

JPMorgan analyst Matthew…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

09/08/21
Fly Intel: Top five analyst upgrades
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy on pullback at Berenberg
09/08/21 Berenberg
Ollie's Bargain Outlet upgraded to Buy from Hold at Berenberg
09/02/21 Piper Sandler
Ollie's shares attractive at current levels, says Piper Sandler
OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

OLLI Ollie's Bargain Outlet
$63.05 /

+1.9 (+3.11%)

Downgrade
Joann downgraded to Equal Weight from Overweight at Wells Fargo » 05:36
12/03/21
12/03
05:36
12/03/21
05:36
JOAN

Joann

$9.34 /

+0.68 (+7.85%)

Wells Fargo analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

10/01/21 Barclays
Joann downgraded to Underweight from Equal Weight at Barclays
09/20/21 Loop Capital
Joann's updated format easier to shop, says Loop Capital
09/07/21 Loop Capital
Joann price target lowered to $15 from $20 at Loop Capital
09/07/21 Barclays
Joann downgraded to Equal Weight from Overweight at Barclays
JOAN Joann
$9.34 /

+0.68 (+7.85%)

  • 12
    Mar
JOAN Joann
$9.34 /

+0.68 (+7.85%)

JOAN Joann
$9.34 /

+0.68 (+7.85%)

Hot Stocks
BeiGene announces three medicines included in NDRL by China NHSA » 05:35
12/03/21
12/03
05:35
12/03/21
05:35
BGNE

BeiGene

$346.46 /

-7.365 (-2.08%)

BeiGene announced that…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

10/12/21
Fly Intel: Top five analyst initiations
10/12/21 Bernstein
BeiGene initiated with Outperform, $431 price target at Bernstein
10/12/21 Bernstein
BeiGene initiated with an Outperform at Bernstein
10/06/21 CLSA
CLSA double upgrades BeiGene to Buy on anti-BTK potential
BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

BGNE BeiGene
$346.46 /

-7.365 (-2.08%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.